Eric  Schiller net worth and biography

Eric Schiller Biography and Net Worth

Chief Technology Officer of KORU Medical Systems

Eric Schiller joined Koru Medical Systems as Chief Technology Officer in December 2025, bringing more than 25 years of experience in medical devices and drug-device combination products. He has deep expertise across product development, engineering, supply chain, and lifecycle management. Prior to joining Koru, Eric held senior leadership roles at Sanofi, most recently serving as Global Head of Device Development Portfolio, where he oversaw more than 80 pipeline assets across Specialty Care, General Medicine, and Vaccines, with approximately 40 planned launches by 2030. Earlier in his career, Eric held leadership positions at Bristol Myers Squibb, Celgene, Becton Dickinson, and Saint-Gobain, where he led global commercialization efforts and advanced innovative drug-delivery technologies. Eric holds an MBA from Seton Hall University and a Bachelor of Science in Mechanical Engineering from the New Jersey Institute of Technology and is a named inventor on multiple U.S. patents.

What is Eric Schiller's net worth?

The estimated net worth of Eric Schiller is at least $20.15 thousand as of May 18th, 2026. Mr. Schiller owns 5,000 shares of KORU Medical Systems stock worth more than $20,150 as of July 22nd. This net worth estimate does not reflect any other investments that Mr. Schiller may own. Learn More about Eric Schiller's net worth.

How do I contact Eric Schiller?

The corporate mailing address for Mr. Schiller and other KORU Medical Systems executives is 24 CARPENTER RD, CHESTER NY, 10918. KORU Medical Systems can also be reached via phone at (845) 469-2042 and via email at [email protected]. Learn More on Eric Schiller's contact information.

Has Eric Schiller been buying or selling shares of KORU Medical Systems?

Eric Schiller has not been actively trading shares of KORU Medical Systems during the past quarter. Most recently, on Monday, May 18th, Eric Schiller bought 5,000 shares of KORU Medical Systems stock. The stock was acquired at an average cost of $3.91 per share, with a total value of $19,550.00. Following the completion of the transaction, the chief technology officer now directly owns 5,000 shares of the company's stock, valued at $19,550. Learn More on Eric Schiller's trading history.

Who are KORU Medical Systems' active insiders?

KORU Medical Systems' insider roster includes Thomas Adams (Chief Financial Officer), James Beck (Director), Adam Kalbermatten (President and Chief Executive Officer), Joseph Manko, Jr. (Director), Christopher Pazdan (Chief Operating Officer), and Eric Schiller (Chief Technology Officer). Learn More on KORU Medical Systems' active insiders.

Are insiders buying or selling shares of KORU Medical Systems?

In the last twelve months, KORU Medical Systems insiders bought shares 4 times. They purchased a total of 28,000 shares worth more than $109,430.00. The most recent insider tranaction occured on June, 11th when insider Adam R Kalbermatten bought 12,500 shares worth more than $49,250.00. Insiders at KORU Medical Systems own 18.5% of the company. Learn More about insider trades at KORU Medical Systems.

Information on this page was last updated on 6/11/2026.

Eric Schiller Insider Trading History at KORU Medical Systems

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/18/2026Buy5,000$3.91$19,550.005,000View SEC Filing Icon  
See Full Table

Eric Schiller Buying and Selling Activity at KORU Medical Systems

This chart shows Eric Schiller's buying and selling at KORU Medical Systems by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

KORU Medical Systems Company Overview

KORU Medical Systems logo
KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey.
Read More

Today's Range

Now: $3.86
Low: $3.83
High: $4.03

50 Day Range

MA: $4.12
Low: $3.83
High: $4.60

2 Week Range

Now: $3.86
Low: $3.20
High: $6.61

Volume

148,768 shs

Average Volume

160,699 shs

Market Capitalization

$177.07 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.41